Clinical Literature Interpretation Flashcards
7 cards from real BCACP practice questions. Tap to flip, then mark Knew It or Still Learning โ missed cards come back until you master them.
Read the first 7 Clinical Literature Interpretation flashcards as text
A cohort study follows patients with and without statin use over 10 years to assess cardiovascular events. What measure of association is most appropriate to report?
Answer: Relative risk (RR)
Relative risk is the preferred measure of association in cohort studies with known incidence rates.
A study has a wide 95% confidence interval crossing 1.0 for an odds ratio. What does this indicate?
Answer: The result is not statistically significant
A 95% CI for an odds ratio that includes 1.0 indicates no statistically significant difference between groups.
Which study design provides the highest level of evidence for evaluating therapeutic interventions?
Answer: Systematic review with meta-analysis of randomized controlled trials
Systematic reviews with meta-analyses of RCTs sit at the top of the evidence hierarchy for therapeutic questions.
In a crossover trial, which design feature helps control for carryover effects?
Answer: Washout period between treatment phases
A washout period allows prior treatment effects to dissipate before the next phase begins, controlling for carryover.
A pharmacist reviews a trial where the primary endpoint was changed after enrollment began but before unblinding. This is an example of:
Answer: Outcome reporting bias
Changing the primary endpoint after trial initiation but before unblinding introduces outcome reporting bias.
A study reports a sensitivity of 92% and specificity of 85% for a diagnostic test. Which statement is correct?
Answer: The test correctly identifies 92% of true positive cases
Sensitivity measures the proportion of true positives correctly identified (92% of diseased patients test positive).
What does the number needed to harm (NNH) represent?
Answer: The number of patients who must receive a treatment for one additional patient to experience harm
NNH = 1/absolute risk increase, representing how many patients need treatment before one additional adverse outcome occurs.